Free Pharmacovigilance Webinar: Only one day left to register!
November 8, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmacovigilance
There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …
FDA clears digital sensor for GSK inhaler
November 8, 2016Manufacturing and Production, Sales and Marketing FDA, GSK, GlaxoSmithKline, Propeller Health, ellipta
The FDA has given 510(k) clearance to a smart inhaler sensor developed by Propeller Health for use with GlaxoSmithKline’s Ellipta …
Coherus knocked back by AbbVie’s Humira patent protection
November 8, 2016Manufacturing and Production, Sales and Marketing AbbVie, Coherus, Humira
Coherus Biosciences, a developer of biosimilars, has suffered a blow in their petition for Inter Partes Review (IPR) of one …
Teva antihypertensive generic duo gets FDA thumbs up
November 7, 2016Manufacturing and Production, Sales and Marketing Azor, FDA, Teva, Tribenzor
Teva has received the approval from the US Food and Drug Administration (FDA) for its generic hypertension treatments Tribenzor (olmesartan …
Targovax announce the appointment of CEO
November 7, 2016Oystein Soug was announced as the new CEO of Targovax, a clinical stage immuno-oncology company dedicated to the development of …
Biogen and Ionis’ spinal muscular atrophy drug meets primary endpoint
November 7, 2016Manufacturing and Production, Research and Development Biogen, Ionis, spinal muscular atrophy
Biogen and Ionis Pharmaceuticals have released news that their investigational treatment for spinal muscular atrophy (SMA), Spinraza (nusinersen), met the …
Free Pharmacovigilance Webinar: Just two days left to register!
November 7, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance
There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …
South Korea’s workforce expands 27% in last four years
November 7, 2016Manufacturing and Production, Sales and Marketing Employment, manufacturing, production, south korea
South Korea’s pharmaceutical workforce has expanded by 27% in the last four years. The growth in jobs is can be …
GSK launches patent infringement action against Pfizer
November 7, 2016Sales and Marketing Bexsero, trumenba
GlaxoSmithKline has filed a patent infringement lawsuit against rival Pfizer over the alleged copying of its popular meningococcal group B …
FDA approves first therapy for paediatric psoriasis treatment
November 7, 2016Sales and Marketing Amgen, Enbrel, paediatric, psoriasis
Amgen’s Enbrel has been given approval by the FDA for expanded use to treat children with chronic moderate-to-severe plaque psoriasis. …
Cancer Research UK enters new oncology partnership
November 7, 2016Sales and Marketing Cancer Research UK, TYG Oncology, oncology
Cancer Research UK (CRUK) and its commercial arm, Cancer Research Technology (CRT), haven entered into an agreement with TYG Oncology …
Nestle backs allergy biotech Aimmune to the tune of $145 million
November 7, 2016Sales and Marketing Aimmune, allergy therapeutics, nestle
Nestle Health Science has invested $145 million in return for a 15% stake in Aimmune Therapeutics. Aimmune pursues food-allergy therapies …
Merck KGaA invests €250 million in production in China
November 4, 2016Manufacturing and Production China, Merck KGaA, Nantong, manufacturing
Merck KGaA inaugurated their Nantong pharmaceutical plant on 4 November. At the same time, Merck also announced that it plans …
Top Ten articles in the pharma industry this week
November 4, 2016Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories
This week has seen pharmaceutical companies release their third quarter profits, good news for some whilst others have attempted to …
Sanofi, Lilly & Novo accused of pricing collusion
November 4, 2016Manufacturing and Production, Medical Communications, Sales and Marketing
Bernie Sanders has continued his assault on pharma pricing after calling out Eli Lilly earlier this week by implicating Lilly, …
Lonza grows manufacturing capability by opening further site
November 4, 2016Medical Communications Lonza, drug product services, manufacturing
Lonza, a Swiss multinational chemical and biotechnology company, has opened a new manufacturing facility in Basel, where their headquarters is …
AstraZeneca’s post-heart attack drug gets NICE recommendation
November 4, 2016Medical Communications, Sales and Marketing AstraZeneca, Brillique, NICE, heart attack
AstraZeneca’s Brillique (ticagrelor) has received final recommendation from the National Institute of Health and Care Excellence (NICE) as a prevention …
Blood cancer sufferers to receive early access to BMS’ Opdivo
November 3, 2016Medical Communications Bristol-Myers Squibb, lyphoma, opdivo
Bristol-Myers Squibb has announced that their immunotherapy drug, Opdivo (nivolumab), will be made available to patients in the UK through …
Clinical trials and their patients: The rising costs and how to stem the loss
November 3, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials
The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …
NICE approves first new drug for breast cancer in a decade
November 3, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
